SGFG
ARMP icon

Silver Grove Financial Group’s Armata Pharmaceuticals ARMP Stock Holding History

Silver Grove Financial Group’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3K Hold
200
– – ﹤0.01% 1773
2026
Q1 		$2.05K Buy
+200
New +$1.68K ﹤0.01% 418

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Silver Grove Financial Group's ARMP Position: Q2 2026 in Review

Silver Grove Financial Group held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 200 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Silver Grove Financial Group first reported a position in ARMP in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.05K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Silver Grove Financial Group held 200 shares of Armata Pharmaceuticals worth $1.3K as of Q2 2026.
  • Silver Grove Financial Group left its Armata Pharmaceuticals share count unchanged in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #1773 holding.
  • Silver Grove Financial Group first reported a position in Armata Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Silver Grove Financial Group's Armata Pharmaceuticals position peaked at $2.05K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.